4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 46,691,176
Number of holders: 51
Total 13F shares, excl. options: 14,593,004
Shares change: +14,015,227
Total reported value, excl. options: $602,432,000
Value change: +$578,482,000
Number of buys: 48
Price: $41.45

Significant Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q4 2020

51 filings reported holding FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14,593,004 shares of 46,691,176 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (3,937,914 shares), FMR LLC (1,594,355 shares), BVF INC/IL (1,106,070 shares), ArrowMark Colorado Holdings LLC (1,063,744 shares), JANUS HENDERSON GROUP PLC (1,021,911 shares), Casdin Capital, LLC (780,555 shares), SB Management Ltd (717,734 shares), PERCEPTIVE ADVISORS LLC (600,256 shares), ALKEON CAPITAL MANAGEMENT LLC (401,885 shares), and Octagon Capital Advisors LP (377,777 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.